(2021) analyzed the expression of miRNAs in AD patients, and found that miR-223-3p and miR-7-5p levels were increased in AD patients, but failed to downregulate NLRP3 and proinflammatory cytokines (53). Here, NLRP3 is linked to Alzheimer disease.